Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia

被引:86
作者
Inwald, DP
Kirkham, FJ
Peters, MJ
Lane, R
Wade, A
Evans, JP
Klein, NJ
机构
[1] Inst Child Hlth, Portex Unit Anaesthesia Intens Care & Resp Med, London WC1N 1EH, England
[2] Inst Child Hlth, Immunol Unit, London, England
[3] Inst Child Hlth, Neurosci Unit, London, England
[4] Inst Child Hlth, Dept Epidemiol & Biostat, London, England
[5] Great Ormond St Hosp Children NHS Trust, Dept Haematol, London WC1N 3JH, England
关键词
platelets; granulocytes; activation; sickle cell disease; hypoxaemia;
D O I
10.1046/j.1365-2141.2000.02353.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We hypothesized that vaso-occlusive events in childhood sickle cell disease (SCD) may relate to inflammatory cell activation as well as interactions between sickle erythrocytes and vascular endothelium. Peripheral blood was examined from 24 children with SCD, of whom 12 had neurological sequelae and seven had frequent painful crises, and 10 control subjects. Platelet (CD62P and CD40L expression) and granulocyte (CD11b expression) activation and levels of platelet-erythrocyte and platelet-granulocyte complexes were determined by flow cytometry. Platelets (P = 0.019), neutrophils (P = 0.02) and monocytes (P = 0.001) were more activated and there were increased platelet-erythrocyte complexes (P = 0.026) in SCD patients compared with controls. Platelet-granulocyte complexes were not raised. There were no differences between the different groups of SCD. As hypoxia activates monocytes, platelets and endothelial cells and causes sickling of SCD erythrocytes, we also investigated 20 SCD patients with overnight pulse oximetry. Minimum overnight saturation correlated with the level of platelet-erythrocyte complexes (Spearman's rho -0.668, P < 0.02), neutrophil CD11b (Spearman's rho -0.466, P = 0.038) and monocyte CD11b (Spearman's rho -0.652, P = 0.002). These findings provide important clues about the mechanism by which SCD patients may become predisposed to vaso-occlusive events.
引用
收藏
页码:474 / 481
页数:8
相关论文
共 32 条
[1]   Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].
Adams, RJ ;
McKie, VC ;
Hsu, L ;
Files, B ;
Vichinsky, E ;
Pegelow, C ;
Abboud, M ;
Gallagher, D ;
Kutlar, A ;
Nichols, FT ;
Bonds, DR ;
Brambilla, D ;
Woods, G ;
Olivieri, N ;
Driscoll, C ;
Miller, S ;
Wang, W ;
Hurlett, A ;
Scher, C ;
Berman, B ;
Carl, E ;
Jones, AM ;
Roach, ES ;
Wright, E ;
Zimmerman, RA ;
Waclawiw, M ;
Pearson, H ;
Powars, D ;
Younkin, D ;
El-Gammal, T ;
Seibert, J ;
Moye, L ;
Espeland, M ;
Murray, R ;
McKinley, R ;
McKinley, S ;
Hagner, S ;
Weiner, S ;
Estow, S ;
Yelle, M ;
Brock, K ;
Carter, E ;
Chiarucci, K ;
Debarr, M ;
Feron, P ;
Harris, S ;
Hoey, L ;
Jacques, K ;
Kuisel, L ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11
[2]   STROKE IN A COHORT OF PATIENTS WITH HOMOZYGOUS SICKLE-CELL DISEASE [J].
BALKARAN, B ;
CHAR, G ;
MORRIS, JS ;
THOMAS, PW ;
SERJEANT, BE ;
SERJEANT, GR .
JOURNAL OF PEDIATRICS, 1992, 120 (03) :360-366
[3]  
BECKLAKE MR, 1954, J CLIN INVEST, V34, P751
[4]   Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64 [J].
Fadlon, E ;
Vordermeier, S ;
Pearson, TC ;
Mire-Sluis, AR ;
Dumonde, DC ;
Phillips, J ;
Fishlock, K ;
Brown, KA .
BLOOD, 1998, 91 (01) :266-274
[5]  
HARGRAVE D, 2000, ARCH CHILDHOOD DIS, V82, pA28
[6]  
Hebbel RP, 1997, J CLIN INVEST, V100, pS83
[7]   CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells [J].
Henn, V ;
Slupsky, JR ;
Gräfe, M ;
Anagnostopoulos, I ;
Förster, R ;
Müller-Berghaus, G ;
Kroczek, RA .
NATURE, 1998, 391 (6667) :591-594
[8]  
HOOVER R, 1979, BLOOD, V54, P872
[9]   Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome [J].
Inwald, DP ;
Peters, MJ ;
Walshe, D ;
Jones, A ;
Davies, EG ;
Klein, NJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (03) :499-502
[10]  
KAUL DK, 1986, BLOOD, V68, P1162